Big Moving Stock keep track of the biggest moving stocks in the market.


Nasdaq: GOOG NFLX BIIB AMZN IBB TSLA WYNN ILMN ALXN GMCR AMGN SLXP COST CNQR SBAC VRTX GILD AAPL MNST
Nyse: ACT V LNKD IVV AGN PXD GS LMT SPG IBM FDX MMM TWC CMI HUM APD PX GD NOC BDX
New Highs: REGN SHW ILMN PSA SPG ORLY GMCR AAP COST GILD AAPL HAIN RTN TRV CELG HD GPC NKE UNH CVS

The Hot Industries

Biotechnology 4
Auto Parts Stores 2
Auto Parts Wholesale 1

The Hot Sectors

Services 7
Healthcare 5
Consumer Goods 3

CELG Stock Chart


CELG
Analyze

Sector:

Healthcare
Daily

Industry:

Biotechnology
Weekly

Employees:

5,100
Monthly

Website:

http://www.celgene.com

CELG Celgene Corporation

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. The company’s commercial stage products include REVLIMID, an oral immunomodulatory drug for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma; VIDAZA, a pyrimidine nucleoside analog to treat intermediate-2 and high-risk MDS, and chronic myelomonocytic leukemia, as well as acute myeloid leukemia (AML); ABRAXANE, a solvent-free chemotherapy product for the treatment of breast, non-small cell lung, pancreatic, and gastric cancers; and POMALYST/IMNOVID for the treatment of multiple myeloma. Its commercial stage products also comprise THALOMID for the patients with multiple myeloma and for the acute treatment of the cutaneous manifestations of erythema nodosum leprosum; ISTODAX to treat cutaneous T-cell lymphoma; and FOCALIN, FOCALIN XR, and RITALIN LA products. The company’s pre clinical and clinical stage products consist of OTEZLA for the treatment of psoriatic arthritis, psoriasis, and ankylosing spondylitis; CC-122 and CC-220 to treat hematological and solid tumor cancers; cellular therapies, such as PDA-001 and PDA-002 for Crohn’s and peripheral arterial diseases; CC-486, to treat MDS, AML, and solid tumors; Sotatercept and ACE-536 for the treatment of anemia in patients with rare blood disorders; CC-223 and CC-115 for lymphomas, hepatocellular, and prostate cancers; and CC-292 for the treatment of chronic lymphocytic leukemia and lymphomas. It has strategic drug discovery collaboration with Abide Therapeutics to enhance the treatment paradigm for patients with immune disorders. Celgene Corporation was founded in 1980 and is headquartered in Summit, New Jersey.

favicon

Pre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, PCP, RTN, POT

22 Oct 2014, 2:16 pmPre-Market Earnings Report for October 23, 2014 : CMCSA, UNP, MMM, CELG, LLY, OXY, CAT, GM, ALXN, PCP, RTN, POT
favicon

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog

22 Oct 2014, 10:37 amBiotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup? - Analyst Blog
favicon

Biotech Stock Roundup: AbbVie Calls off Shire Acquisition, Will Amgen Consider Breakup?

22 Oct 2014, 8:18 amWill Amgen (AMGN) go the Abbott (ABT) way and split into two separate companies?
favicon

Celgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog

21 Oct 2014, 4:32 pmCelgene (CELG) Q3 Earnings to Be Overrun by Expenses? - Analyst Blog
favicon

Celgene (CELG) Q3 Earnings to Be Overrun by Expenses?

21 Oct 2014, 1:50 pmCelgene (CELG) is scheduled to report third-quarter 2014 results on Oct 23.
favicon

Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene

15 Oct 2014, 7:28 amLONDON, October 15, 2014 /PRNewswire/ -- Investor-Edge has initiated coverage on the following equities: ImmunoGen Inc. (NASDAQ: IMGN), Arrowhead Research Corporation (NASDAQ: ARWR), Chimerix Inc. (NASDAQ: CMRX), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), and Celgene Corporation...
favicon

Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene

14 Oct 2014, 6:45 amNEW YORK, October 14, 2014 /PRNewswire/ -- Today, Analysts Review released its research reports regarding Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Lakeland Industries Inc. (NASDAQ: LAKE), Endo International plc (NASDAQ: ENDP), Actavis plc (NYSE: ACT) and Celgene Corporation (NASDAQ:...
favicon

Critical Alerts For Exxon Mobil, Celgene, Verizon, Intercept Pharmaceuticals and Lockheed Martin Released By ...

8 Oct 2014, 7:44 amCHICAGO, Oct. 8, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for XOM, CELG, VZ, ICPT and LMT. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note: You...
favicon

Celgene Corporation Shares Could Head Higher

30 Sep 2014, 10:15 amCelgene Corporation  (NASDAQ: CELG ) has been correcting a bit over the last week along with the rest of the market. As opposed to some parts of the market (small caps, core international and certain industry ...
favicon

'Fast Money' Recap: What Market? The Focus Remains on Apple

25 Sep 2014, 3:28 ama NEW YORK (TheStreet) -- The S&P 500 was able to rally on Wednesday, closing upa0.78%.a However, the trading panel on CNBC's "Fast Money" TV show discussed Apple instead, which fell 1% on the day after the company announced it will discontinue its iOS 8 update for the time being.a Guy Adami, managing director of stockmonster.com, thinks the stock is likely to drift lower in the coming weeks ...